Friday, April 26, 2024
4/26/2024
The goal of the King County Opioid Treatment Access Program (KCOTAP) is to decrease opioid overdose-related deaths in King County by expanding access to naloxone and outreaching to individuals who have experienced an overdose. KCOTAP will provide training on naloxone prescribing best practices to providers at the Seattle King County Department of Public Health’s (SKCDPH’s) 9 clinic sites plus the 57 clinic sites of our five partner FQHCs. The project will serve King County FQHC patients with opioid use disorder, whom we estimate to number 34,300 individuals (14% of all patients served annually). KCOTAP will also connect SKCDPH patients who have experienced a drug overdose with appropriate treatment, including MAT, counseling and behavioral therapies via a phone-based post-overdose intervention. We estimate 693 patients per year will be eligible for this intervention. The current rate of opioid-caused deaths in King County is 5.5 times greater among American Indian/Alaskan Natives and 1.3 times greater among Black/African Americans than for (non-Hispanic) whites, so these will be additional populations of focus in order to address disparities. The measurable objectives of the program are as follows: • O1: By May 1 2019, 90% of SKCDPH pharmacists will have received training on naloxone prescribing procedures and formulary. • O2: By December 1, 2019, 90% of SKCDPH prescribing providers will have received training on naloxone prescription and patient counseling. • O3: By Sept 1, 2020, 70% of prescribing providers and pharmacists at 5 King County FQHCs will have received training on naloxone prescription and patient counseling. • O4: By Aug 30, 2020, SKCDPH prescribing providers have dispensed naloxone to 80% of patients diagnosed with opioid use disorder. • O5: By Aug 30, 2024, a social worker will attempt to contact 100% of SKCDPH patients who received emergency medical services for opioid overdose to provide outreach regarding appropriate treatment, including MAT, appropriate counseling, and behavioral therapies. • O6: By Aug 30, 2024, 15% of SKCDPH patients who experienced a drug overdose are connected with appropriate treatment and initiate treatment, including MAT, appropriate counseling and behavioral therapies. • O7: By August 30, 2024, the number of annual opioid-related deaths among SKCDPH patients has decreased by 15% from baseline.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
